Moleculin, LLC   Report issue

For profit Phase 1 Phase 2
Founded: Houston TX United States (2006)

Organization Overview

First Clinical Trial
2013
NCT01826201
First Marketed Drug
None
First NDA Approval
None
Last Known Activity
2021

Timeline

NOW
  • Now

Mergers & Acquisitions

Historical Acquisition Tree

Alternative names

Moleculin Biotech, Inc.